FUJIFILM Diosynth Biotechnologies vs ReciBioPharm: CDMO Comparison
How does FUJIFILM Diosynth Biotechnologies compare to ReciBioPharm?
As of Aug 2026, FUJIFILM Diosynth Biotechnologies: no FDA inspections on file, 35 EMA/MHRA GMP certificates. Signal Score 86.7. ReciBioPharm: no FDA inspections on file, 3 EMA/MHRA GMP certificates. Signal Score 82.9. Counts are the established FDA, EMA and MHRA records on each profile. CDMOs cannot pay to change a score.
Side-by-side comparison of FUJIFILM Diosynth Biotechnologies and ReciBioPharm on independent FDA inspections, EMA and MHRA GMP certificates, clinical-program activity, and CDMO Signal Score. Data sourced from FDA, EMA EudraGMDP, MHRA GMDP, and ClinicalTrials.gov.
Key differences
- FUJIFILM Diosynth Biotechnologies holds 29 active EMA GMP certificates; ReciBioPharm does not appear in EudraGMDP.
Across the cross-modality scorecard, FUJIFILM Diosynth Biotechnologies carries the higher composite Signal Score — but the right choice depends on the specific modality, phase, and geography of the program.
Frequently asked: FUJIFILM Diosynth Biotechnologies vs ReciBioPharm
How does FUJIFILM Diosynth Biotechnologies compare to ReciBioPharm?
On CDMO Signal's composite Signal Score, FUJIFILM Diosynth Biotechnologies is 87/100 and ReciBioPharm is 83/100; European coverage is 35 active EMA+MHRA certificates for FUJIFILM Diosynth Biotechnologies vs 3 for ReciBioPharm. Both are tracked in the CDMO Signal directory. The scorecard above breaks down every metric side by side — use it alongside each CDMO's individual profile for the full regulatory and clinical footprint.
How do FUJIFILM Diosynth Biotechnologies and ReciBioPharm compare on European GMP coverage?
FUJIFILM Diosynth Biotechnologies holds 29 active EMA GMP certificates and 6 MHRA / UK certificates. ReciBioPharm holds 0 active EMA GMP certificates and 3 MHRA / UK certificates. Use these counts as a proxy for the breadth of each CDMO's European regulatory footprint.
What does the Signal Score gap mean in practice?
FUJIFILM Diosynth Biotechnologies carries a Signal Score of 87/100 and ReciBioPharm carries 83/100 — essentially tied for FUJIFILM Diosynth Biotechnologies. The Signal Score combines quality (FDA inspections + EMA/MHRA GMP), operational performance, financial stability, and capacity intelligence. CDMOs cannot pay to influence their score.
Use the free AI matchmaker to weigh both against your specific requirements — capacity, modality, regulatory record, geography — and surface other qualified options.
Find & compare CDMOs →